Mylan Laboratories, Inc. (MYL)

zimn0016 (75.71) Submitted: 9/27/07 1:03 AM : Start Price: $15.62 MYL Score: -1.91

An established company with a PEG well below 1, and insider buying. PFE is lagging because all their drugs are going generic...well guess who gets to make those drugs now.

Report this Post Replies: 0 | Reply | Permalink

NetscribePhrmtcl (94.21) Submitted: 12/13/06 8:09 AM : Start Price: $20.71 MYL Score: -28.77

Mylan Labs knows that ‘you may not recognize its drugs but will appreciate the prices’. Mylan Labs is one of the largest manufacturers of prescription generic drugs in the US with its pharmaceutical cabinet full of 150 products, including anti-biotic...

Report this Post Replies: 1 | Reply | Permalink

DouglasRich (< 20) Submitted: 1/29/08 9:30 AM : Start Price: $14.68 MYL Score: 7.12

Mylan is known for making good quality, reliable generic pharmaceutical products, but I think their primary drawback is they haven't found a way to outcompete the generic market. In the pharmacy, cheaper generics are preferred to Mylan's oftentimes ...

Report this Post Replies: 0 | Reply | Permalink

caidencollett07 (87.57) Submitted: 3/27/08 3:57 PM : Start Price: $11.87 MYL Score: 12.33

Reasonable Price, I expect a gain in the generic drug industry.

Report this Post Replies: 0 | Reply | Permalink

Zwieback59 (55.24) Submitted: 11/18/06 2:21 AM : Start Price: $20.67 MYL Score: -29.95

increased generic drug useage and major brand trustworthiness... aggressive business practices and competitive pricing. First out of gate with new generics... solid supplier of generics with very few FDA problems. Good legal offense and defense re...

Report this Post Replies: 0 | Reply | Permalink

CycleFreak7 (62.23) Submitted: 2/25/07 11:14 AM : Start Price: $21.78 MYL Score: -29.58

Despite being up 9.3% YTD 2007, it has recently pulled back from the high hit on 2-Feb of $22.61 for a 3.5% drop to $21.82.

Generics are the pharma of the future. Democrats want health care spending brought under control and will mandate more usage...

Report this Post Replies: 0 | Reply | Permalink

boiler1111 (98.67) Submitted: 2/22/07 9:40 AM : Start Price: $20.14 MYL Score: -27.67

Generics will continue to grow share of overall drug market. Not just growth, though, HUGE growth. In fact, by 2010, generics will have 80% share as opposed to <50% just recently. This whole sector will outperform, but I pick MYL as the one with t...

Report this Post Replies: 0 | Reply | Permalink

JRtrader08 (99.83) Submitted: 8/10/08 10:24 PM : Start Price: $14.05 MYL Score: -9.11

The health care sector in general is very strong, and Mylan just broke out of a 1-year downtrend. After carving out a bottom over the last few months, the stock finally broke out of consolidation on heavy volume last week and this looks like it coul...

Report this Post Replies: 0 | Reply | Permalink

LemmingsRcoming (77.76) Submitted: 2/11/08 4:41 PM : Start Price: $12.97 MYL Score: 3.73

My method for rating stocks is pretty simple. Since our definition of “The Market” is the S&P 500 Index, I have done an extensive analysis of these companies. I simply did a multiple regression comparing the per share data like dividend, book value...

Report this Post Replies: 0 | Reply | Permalink

zolibork (< 20) Submitted: 7/17/07 9:32 AM : Start Price: $17.95 MYL Score: -11.39

Near 52 Month Low





Chance to participate in a Private Equity type situation, as Mylan is using a lot of debt to finance the Merck generic acquisition. As this is paid down, Enterprise Value accrues to stockholders

Report this Post Replies: 0 | Reply | Permalink